Cargando…
Improving properties of the nucleobase analogs T-705/T-1105 as potential antiviral
In this minireview we describe our work on the improvement of the nucleobase analogs Favipiravir (T-705) und its non-fluorinated derivative T-1105 as influenza and SARS-CoV-2 active compounds. Both nucleobases were converted into nucleotides and then included in our nucleotide prodrugs technologies...
Autores principales: | Jia, Xiao, Ganter, Benedikt, Meier, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553380/ https://www.ncbi.nlm.nih.gov/pubmed/34728864 http://dx.doi.org/10.1016/bs.armc.2021.08.002 |
Ejemplares similares
-
Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication
por: Cai, Lei, et al.
Publicado: (2017) -
T-705-Derived Prodrugs Show High Antiviral Efficacies against a Broad Range of Influenza A Viruses with Synergistic Effects When Combined with Oseltamivir
por: Ganter, Benedikt, et al.
Publicado: (2023) -
Nucleoside Analogs with Fleximer Nucleobase
por: Chudinov, Mikhail V.
Publicado: (2020) -
Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs
por: Sun, Ren, et al.
Publicado: (2013) -
Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies
por: Soto-Acosta, Ruben, et al.
Publicado: (2021)